xc8
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Sep 20, 2016 (NCT03450434)
Timeline
Indications
Mechanism of action
- Glutaminyl-peptide cyclotransferaseINHIBITOR
QPCT inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05273619 | Phase 3 | Apr 5, 2022 | Valenta Pharm JSC |
| NCT05269329 | Phase 2 | Apr 26, 2021 | Valenta Pharm JSC |
| NCT03450434 | Phase 2 | Sep 20, 2016 | EURRUS Biotech GmbH, Pharmenterprises LLC |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Valenta Pharm JSC | For profit | 2 | 2 | 2 | 2021 |
| EURRUS Biotech GmbH | For profit | 1 | 0 | 1 | 2016 |
| Pharmenterprises LLC | For profit | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1